Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2021
Same author

Small airway loss in the physiologically ageing lung: a cross-sectional study in unused donor lungs.

The Lancet. Respiratory medicine·2020
Same author

Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

The Lancet. Respiratory medicine·2020
Same author

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Thorax·2018
Same author

Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?

Archivos de bronconeumologia·2018
Same author

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).

International journal of chronic obstructive pulmonary disease·2018
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: May 25, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

La enfermedad pulmonar obstructiva crónica es una enfermedad pulmonar obstructiva crónica.

Marc Decramer1, Wim Janssens, Marc Miravitlles

  • 1Respiratory Division, University Hospital, University of Leuven, Leuven, Belgium. marc.decramer@uzleuven.be

Lancet (London, England)
|February 9, 2012
PubMed
Resumen
Este resumen es generado por máquina.

La enfermedad pulmonar obstructiva crónica (EPOC) implica la obstrucción progresiva del flujo de aire y la inflamación, a menudo empeorada por infecciones. Los tratamientos actuales se centran en el alivio de los síntomas, y la investigación futura apunta a terapias modificadoras de la enfermedad.

Más Videos Relacionados

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Videos de Experimentos Relacionados

Last Updated: May 25, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Área de la Ciencia:

  • Pulmonología Pulmonología.
  • Medicina de las vías respiratorias Medicina de las vías respiratorias

Sus antecedentes:

  • La enfermedad pulmonar obstructiva crónica (EPOC) es una afección respiratoria progresiva caracterizada por una limitación irreversible del flujo de aire, inflamación de las vías respiratorias y efectos sistémicos.
  • Fumar tabaco es la causa principal, pero los factores genéticos y ambientales también contribuyen a la patogénesis de la EPOC.
  • Las exacerbaciones, frecuentemente desencadenadas por infecciones, empeoran significativamente la gravedad de la EPOC, especialmente en etapas avanzadas.

Objetivo del estudio:

  • Para esbozar las características clave de la enfermedad pulmonar obstructiva crónica (EPOC).
  • Para discutir las causas primarias y los factores que contribuyen a la EPOC.
  • Revisar las estrategias actuales de tratamiento y sugerir futuras direcciones de investigación para la EPOC.

Principales métodos:

  • Revisión de la literatura y síntesis de los conocimientos actuales sobre la EPOC.
  • Análisis de los factores etiológicos, la patobiología y los desencadenantes de la exacerbación en la EPOC.
  • Evaluación de los enfoques terapéuticos actuales, incluidos los broncodilatadores y los corticosteroides inhalados.

Principales resultados:

  • La EPOC se define por la obstrucción progresiva del flujo de aire, la inflamación y las comorbilidades como las enfermedades cardíacas y el cáncer de pulmón.
  • Las infecciones bacterianas y virales son los principales contribuyentes a las exacerbaciones de la EPOC, que representan hasta el 78% en casos graves.
  • Los broncodilatadores (agonistas de β2, anticolinérgicos) son el tratamiento primario, ofreciendo potencialmente alguna modificación de la enfermedad.

Conclusiones:

  • El manejo de la EPOC depende de los broncodilatadores para aliviar los síntomas y potencialmente modificar el curso de la enfermedad.
  • La investigación adicional es crucial para desarrollar nuevos agentes terapéuticos que puedan alterar significativamente la progresión de la EPOC.
  • Comprender la compleja interacción de factores genéticos, ambientales e infecciosos es clave para avanzar en el tratamiento de la EPOC.